With this background, Xin et al. (2023) [132], thus, synthesized a nanocomplex conjugated to the platinum IV Pt(IV)-complex and LA to combat the Gram-negative bacteria, Fusobacterium nucleatum (Fn), that promotes chemoresistance in oxaliplatin chemotherapy against CRC. Here, FN1 is linked to colorectal carcinoma.